Results 161 to 170 of about 32,053 (378)
Somatic cell reprogramming for Parkinson's disease treatment
The fundamental purpose of cell reprogramming to treat Parkinson's disease is to generate dopaminergic neurons (DAN) and do transplantation. There are two ways to accomplish this. One method is to induce cells into induced DA neurons (iDAN) directly or to induce cells into induced pluripotent stem cells and ultimately into iDAN in vitro. Another option
Xiaozhuo Li, Kevin Fang, Fengping Wang
wiley +1 more source
Distribution of Tyrosine Hydroxylase‐Immunoreactive Neurones in the Diencephalon and Mesencephalon of the Coypu (Myocastor coypus) [PDF]
Hilda Liliana Sánchez +4 more
openalex +1 more source
Tyrosine Hydroxylase-Immunopositive Cells and Melanin in the Mesencephalon of Yugan Black-Bone Fowl
Meng Chu +6 more
openalex +2 more sources
Molecular imprinting for neurology: Materials, applications, and limitations
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma +3 more
wiley +1 more source
Propylparaben is widely used as a preservative in food, cosmetics, and pharmaceuticals. Concerns regarding its potential teratogenic effects have been raised.
Hendry Saragih +6 more
doaj +1 more source
Modern AI systems can now synthesize coherent multimedia experiences, generating video and audio directly from text prompts. These unified frameworks represent a rapid shift toward controllable and synchronized content creation. From early neural architectures to transformer and diffusion paradigms, this paper contextualizes the ongoing evolution of ...
Charles Ding, Rohan Bhowmik
wiley +1 more source
Abstract Background Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremors, rigidity, and bradykinesia. Structural brain changes, including atrophy in the midbrain, basal ganglia, and cortical regions such as the frontal and temporal lobes, are observed in advanced stages.
Suraiya Mangra +5 more
wiley +1 more source
A Biomarker‐Based Classification of Corticobasal Syndrome
Abstract Background Corticobasal syndrome (CBS) is a clinically defined syndrome with progressive movement and cortical dysfunction, caused by various underlying pathologies, most commonly tau‐predominant pathologies such as progressive supranuclear palsy and corticobasal degeneration, or Alzheimer's disease (AD).
Carla Palleis +13 more
wiley +1 more source

